Home › All Victims › Ondine Biomedical

Ondine Biomedical

incransom

This record tracks a ransomware attack claimed by the incransom group against Ondine Biomedical. It collects the publicly disclosed attack details — sector, location and timeline — as published on the operator's leak site and indexed by Breach House.

Country
Canada
Business Category
Healthcare / Pharma
Employees
51-100
Discovered
2026-02-16
Published
February 16, 2026
Victim ID
JJFFiAM47uOz

Attack Summary

Ondine Biomedical Inc. is a Canadian headquartered company led by founder and CEO, Carolyn Cross. Ondine has developed a patented, photodisinfection technology platform used in treatment and prevention therapies for a broad-spectrum of pathogens - including multidrug-resistant strains. Photodisinfection, which is not currently approved in the United States We will publish all the information next week.

Visit Website Original Post View Group: incransom
Legal Disclaimer: This ransomware victim record reflects information published on the operator's leak site. Breach.house does not acquire, download, host, access or redistribute unlawfully obtained data. It indexes only publicly visible information posted by ransomware, breach and infostealer operators and open web sources, without accessing the underlying stolen content. The service supports public awareness, legitimate research and cyber-resilience.